Literature DB >> 405869

Proton irradiation of small choroidal malignant melanomas.

E S Gragoudas, M Goitein, A M Koehler, L Verhey, J Tepper, H D Suit, R Brockhurst, I J Constable.   

Abstract

Five patients with choroidal malignant melanomas were treated with proton irradiation with a cyclotron. We developed an accurate method of aiming the proton beam within the eye. Four to five tantalum rings, 2 mm in diameter, were sutured to the sclera at the edges of the tumor, which is localized by indirect ophthalmoscopy and transillumination. The rings were used as markers for stereotactic radiography to align precisely the tumors with the proton beam. The patients were given a total tumor dose of 4,730 to 6,670 rads, delivered in five equal fractions, over a period of eight to nine days. All patients tolerated the treatments well without any adverse effects. The tumor response to therapy could not be evaluated at the completion of treatment since there was no immediate observable reaction of the tumor or of the surrounding retina. Although there has been no definite regression in any patient, we observed a change in the "color" of the tumor in the first two patients and resolution of two serous retinal detachments.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 405869     DOI: 10.1016/0002-9394(77)90133-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Where is the superiority of proton radiation for ocular tumours?

Authors:  Nikolaos E Bechrakis; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-07       Impact factor: 3.117

3.  Monte Carlo calculations and measurements of absorbed dose per monitor unit for the treatment of uveal melanoma with proton therapy.

Authors:  Nicholas Koch; Wayne D Newhauser; Uwe Titt; Dan Gombos; Kevin Coombes; George Starkschall
Journal:  Phys Med Biol       Date:  2008-02-25       Impact factor: 3.609

4.  1996 Jules Gonin Lecture of the Retina Research Foundation. Long-term results after proton irradiation of uveal melanomas.

Authors:  E S Gragoudas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-05       Impact factor: 3.117

5.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

Review 6.  Emerging treatments for choroidal metastases.

Authors:  Connie J Chen; Allison N McCoy; Julie Brahmer; James T Handa
Journal:  Surv Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 6.048

7.  Proton irradiation of malignant melanoma of the ciliary body.

Authors:  E S Gragoudas; M Goitein; A Koehler; M S Wagner; L Verhey; J Tepper; H D Suit; R J Schneider; K N Johnson
Journal:  Br J Ophthalmol       Date:  1979-02       Impact factor: 4.638

8.  Proton beam radiotherapy in the management of uveal melanoma: Clinical experience in Scotland.

Authors:  Samir Aziz; Alex Taylor; Andrzej McConnachie; Alex Kacperek; Ewan Kemp
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Feasibility of using PRESAGE® for relative 3D dosimetry of small proton fields.

Authors:  Li Zhao; Joseph Newton; Mark Oldham; Indra J Das; Chee-Wai Cheng; John Adamovics
Journal:  Phys Med Biol       Date:  2012-10-26       Impact factor: 3.609

10.  Dose perturbations from implanted helical gold markers in proton therapy of prostate cancer.

Authors:  Annelise Giebeler; Jonas Fontenot; Peter Balter; George Ciangaru; Ronald Zhu; Wayne Newhauser
Journal:  J Appl Clin Med Phys       Date:  2009-01-27       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.